Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
MEDTOX Scientific Receives FDA 510(k) Clearance for Additional Three Drugs On the PROFILE(r)-V MEDTOXScan(r) Drugs-of-Abuse Test System
MEDTOX Scientific Announces Second Quarter Results
MEDTOX Scientific Announces Second Quarter Conference Call
MEDTOX Scientific Announces First Quarter Results; Clinical Lab Revenues Increase of 36%
MEDTOX Scientific Announces First Quarter Results
MEDTOX Scientific Announces First Quarter Conference Call and Annual Meeting Date
Photo Release -- MEDTOX Scientific Receives FDA 510(K) Clearance for PROFILE(r)-V MEDTOXScan(r) Drugs-of-Abuse Test System
MEDTOX Scientific Announces Results for Fourth Quarter and Year-End 2008
MEDTOX Scientific Announces Fourth Quarter and Year-End Conference Call
MEDTOX Scientific Announces Third Quarter Results, Clinical Lab Revenues Increase 26 Percent
MEDTOX Scientific Announces Third Quarter Conference Call
MEDTOX Scientific Announces Second Quarter Results - Jul 16 2008 7:11AM
MEDTOX Scientific Announces Second Quarter Conference Call
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
